depomed

  1. Assertio ACTH

    This is from the Assertio website about synacthen: Our initial focus is the development of Cosyntropin (synthetic ACTH depot), a unique, late-stage product that, upon approval, will provide U.S. patients, physicians and payers with an alternative option. The site also states that it is in...
  2. 90 Sales Force for Nerology, up from 40

    ...and Neurology Revenues down in Q4 2017? What is going on? Nobody working anymore?